← The Wire
CGENNasdaq
COMPUGEN LTD
Biological Products, (No Diagnostic Substances) · L3 · CIK 1119774
Compugen Ltd. discovers and develops cancer immunotherapies using its AI/ML platform
$193M
Market cap
$2.16
Last close
+3.4%
1D
+4.3%
5D
257K
Volume
Price · last 39 sessions-18.2%
May 4L $1.96 · H $3.03Jun 29
435
Total filings
May 18, 2026
Last filing
12/31
Fiscal year end
424B5424B5Jan 31, 2023424B5424B5Mar 12, 2020424B5424B5Mar 11, 2020424B5424B5Jun 18, 2018424B5424B5May 25, 2018424B5424B5Feb 28, 2014424B5424B5Feb 27, 2014424B5424B5Sep 1, 2011424B5424B5Oct 30, 2009
Insider Activity
In the 90 days to Mar 26, 2026: 1 sold $24K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | Levine ZuritSVP, Business Development | Sell | 11,875 | $2.04 | $24K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance